Shenzhen Edge Medical Co. Ltd. announced the full exercise of the over-allotment option and the conclusion of the stabilization period following its recent offering. The company confirmed that it will continue to comply with public float requirements after these actions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Edge Medical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260204-12014876), on February 04, 2026, and is solely responsible for the information contained therein.
Comments